Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Myozenin 1 antibody (AA 42-89)

This anti-Myozenin 1 antibody is a Rabbit Polyclonal antibody detecting Myozenin 1 in WB, ELISA and IHC. Suitable for Human.
Catalog No. ABIN7570414

Quick Overview for Myozenin 1 antibody (AA 42-89) (ABIN7570414)

Target

See all Myozenin 1 (MYOZ1) Antibodies
Myozenin 1 (MYOZ1)

Reactivity

  • 39
  • 24
  • 9
  • 4
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 35
  • 4
Rabbit

Clonality

  • 36
  • 4
Polyclonal

Conjugate

  • 21
  • 4
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This Myozenin 1 antibody is un-conjugated

Application

  • 23
  • 16
  • 13
  • 12
  • 4
  • 3
  • 3
  • 2
  • 2
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
  • Binding Specificity

    • 7
    • 6
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 42-89

    Purpose

    Anti-Human MYOZ1 Polyclonal Antibody

    Purification

    Antigen affinity purification.

    Immunogen

    E. coli - derived recombinant Human MYOZ1 (Arg42-Lys89).

    Isotype

    IgG
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C,-80 °C

    Storage Comment

    Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
  • Target

    Myozenin 1 (MYOZ1)

    Alternative Name

    MYOZ1

    Background

    Filamin-, actinin- and telethonin-binding protein, MYOZ1, Calsarcin-2, MYOZ, Protein FATZ, Myozenin-1

    UniProt

    Q9NP98
You are here:
Chat with us!